iifl-logo

Accretion Pharmaceuticals Ltd Share Price

64.9
(-2.48%)
May 30, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open64.65
  • Day's High67.5
  • 52 Wk High82.95
  • Prev. Close66.55
  • Day's Low63.25
  • 52 Wk Low 64.25
  • Turnover (lac)47.5
  • P/E20.16
  • Face Value10
  • Book Value0
  • EPS3.22
  • Mkt. Cap (Cr.)72.14
  • Div. Yield0
View All Historical Data
No Records Found

Accretion Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

64.65

Prev. Close

66.55

Turnover(Lac.)

47.5

Day's High

67.5

Day's Low

63.25

52 Week's High

82.95

52 Week's Low

64.25

Book Value

0

Face Value

10

Mkt Cap (₹ Cr.)

72.14

P/E

20.16

EPS

3.22

Divi. Yield

0

Accretion Pharmaceuticals Ltd Corporate Action

No Record Found

Accretion Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Accretion Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

31 May, 2025|02:03 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 100.00%

Foreign: 0.00%

Indian: 100.00%

Non-Promoter- 0.00%

Institutions: 0.00%

Non-Institutions: 0.00%

Custodian: 0.00%

Share Price

Accretion Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024

Equity Capital

4

Preference Capital

0

Reserves

1.49

Net Worth

5.49

Minority Interest

View Balance Sheet

No Record Found

View Profit & Loss

No Record Found

View Cash Flow

No Record Found

View Ratios

No Record Found

Accretion Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,677.6

94.024,02,680.392,000.460.957,107.14101.44

Divis Laboratories Ltd

DIVISLAB

6,612

79.461,75,531.816670.452,536561.08

Cipla Ltd

CIPLA

1,465.7

24.021,18,307.21,485.41.094,254.47397.44

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,174.7

56.381,07,416.074741.012,385224.33

Dr Reddys Laboratories Ltd

DRREDDY

1,251.2

19.531,04,452.951,200.70.645,546.3345.81

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Accretion Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Executive Director

Mayur Popatlal Sojitra

Director & CFO

Harshad Nanubhai Rathod

Managing Director

Vivek Ashok Kumar Patel

Executive Director

Hardik Mukundbhai Prajapati

Independent Director

Shyam Bhadresh Kapadia.

Independent Director

Vijay Bharatbhai Anadkat

Independent Director

Grishma A Shewale

Company Sec. & Compli. Officer

Bhavika Dhaval Makadia

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products. Thus, the foundation of Accretion Pharmaceuticals was laid down, which was started as a Partnership Firm in the name of M/s Accretion Pharmaceuticals, pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in year 2014. Thereafter, the Partnership Firm was converted into a Limited Company in the name of Accretion Pharmaceuticals Limited and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.Presently, Company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. either for direct sales, loan licence and/or contract manufacturing.The Company is ISO 9001:2015, ISO 14001:2015 and ISO 22000:2018 certified and is led by a experienced board of directors, and a professional and experienced management team with extensive experience in the pharmace
Read More

Company FAQs

What is the Accretion Pharmaceuticals Ltd share price today?

The Accretion Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹64.9 today.

What is the Market Cap of Accretion Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Accretion Pharmaceuticals Ltd is ₹72.14 Cr. as of 30 May ‘25

What is the PE and PB ratio of Accretion Pharmaceuticals Ltd?

The PE and PB ratios of Accretion Pharmaceuticals Ltd is 20.16 and 1.89 as of 30 May ‘25

What is the 52 Week High and Low of Accretion Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Accretion Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Accretion Pharmaceuticals Ltd is ₹64.25 and ₹82.95 as of 30 May ‘25

What is the CAGR of Accretion Pharmaceuticals Ltd?

Accretion Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at N/I%, 3 Month at N/I% and 1 Month at -21.76%.

What is the shareholding pattern of Accretion Pharmaceuticals Ltd?

The shareholding pattern of Accretion Pharmaceuticals Ltd is as follows:
Promoters - 73.50 %
Institutions - 3.17 %
Public - 23.33 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.